Hong Kong Asia Heart Centre Funding, Investors & Competitors

Hong Kong Asia Heart Centre has raised $550M across 2 funding rounds, most recently a $400M Series D in February 2022.

Last Hong Kong Asia Heart Centre funding round

$400M

Series D · Feb 2022

Cumulative funding Hong Kong Asia Heart Centre raised

$550M

across 2 funding rounds

Key investors in Hong Kong Asia Heart Centre

  • General Atlantic
  • Legend Capital
  • Primavera Capital Group
  • BOCOM Intl Hldgs Co
  • Country Garden Venture Capital
  • Taikang Insurance Group
  • ABC International
  • Hudson Bay Capital Management

Hong Kong Asia Heart Centre Overview

About Hong Kong Asia Heart Centre

Hong Kong Asia Heart Centre is a specialist cardiovascular clinic chain with locations in Kowloon and Hong Kong Island since 1999. It offers non-invasive diagnostics like CT angiography, echocardiography, and Holter monitoring alongside angioplasty and pacemaker implants. The team performs over 2,000 procedures yearly, treating coronary artery disease for patients from mainland China and Southeast Asia.


Founded

1999

HQ

Hong KongHong Kong

Status

Privately held

Customer focus

B2C

Revenue model

Services

Hong Kong Asia Heart Centre Funding History

Hong Kong Asia Heart Centre has raised a total of $550M across 2 funding rounds.

Hong Kong Asia Heart Centre's first fundraising round was a $150M strategic investment round in September 2018. The most recent completed round was a $400M Series D in February 2022.

Hong Kong Asia Heart Centre funding rounds

Hong Kong Asia Heart Centre funding rounds
DateStageInvestorsRaisedDeal Summary
Feb 2022Series DCountry Garden Venture Capital (lead); Primavera Capital Group (lead); ICBC International; BOCOM Intl Hldgs Co; Taikang Insurance Group; Hudson Bay Capital Management; ABC International; General Atlantic; Sherpa Ventures; Legend Capital$400MHong Kong Asia Heart Centre (also referred to as Hong Kong Asia Medical Group in some sources) is a cardiovascular specialist chain founded in 1999, providing various cardiovascular assessment and surgical services with a professional medical team experienced in heart disease treatment. In 2022, the company raised a USD400m Series D round led by Country Garden Venture Capital and Primavera Capital Group, with participation from Taikang Life Insurance (Taikang Insurance Group), ICBC International, ABC International, BOCOM International (BOCOM Intl Hldgs Co), Hudson Bay Capital, Sherpa Venture Capital (Sherpa Ventures), and follow-on investments from Legend Capital and General Atlantic. The investment supports the hospital chain's growth in the healthcare sector, focusing on specialized cardiac care in Hong Kong and potentially broader Asia. The deal highlights interest from prominent China-based and international investors in Asian healthcare, particularly specialized hospitals amid regional medical demands.
Sep 2018Strategic investmentGeneral Atlantic (lead)$150M-

Who has invested in Hong Kong Asia Heart Centre?

10 investors have backed Hong Kong Asia Heart Centre across its funding rounds, including General Atlantic, Legend Capital, Primavera Capital Group, BOCOM Intl Hldgs Co, Country Garden Venture Capital and Taikang Insurance Group.

Lead investors include Country Garden Venture Capital, Primavera Capital Group and General Atlantic.


Hong Kong Asia Heart Centre Investors

Investors in Hong Kong Asia Heart Centre by funding rounds participated
InvestorHQRoundsRoleFirst check
General AtlanticUnited StatesNew York City, NY2LeadSep 2018
ICBC InternationalHong KongHong Kong1ParticipantFeb 2022
BOCOM Intl Hldgs CoChinaHong Kong1ParticipantFeb 2022
Taikang Insurance GroupChinaBeijing1ParticipantFeb 2022
Hudson Bay Capital ManagementUnited StatesNew York City, NY1ParticipantFeb 2022
ABC InternationalHong KongHong Kong1ParticipantFeb 2022
Primavera Capital GroupChinaBeijing1LeadFeb 2022
Sherpa VenturesSouth KoreaSeoul1ParticipantFeb 2022

This data is available for Pro users. Sign up to see all 10 Hong Kong Asia Heart Centre investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Hong Kong Asia Heart Centre Competitors

Hong Kong Asia Heart Centre competitors include listed companies like HCA Healthcare, Alcon, Fresenius and Dr. Sulaiman Al Habib, and private ones like IVC Evidensia and Luz Saude.

Public and private companies comparable to Hong Kong Asia Heart Centre
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
HCA HealthcareUnited StatesUnited StatesPublicly listed$76B$16B$93B1.9x
AlconSwitzerlandSwitzerlandPublicly listed$10B$2.6B$31B3.3x
FreseniusGermanyGermanyPublicly listed$26B$4.2B$30B1.6x
Dr. Sulaiman Al HabibSaudi ArabiaSaudi ArabiaPublicly listed$3.7B$927M$21B5.9x
IVC EvidensiaUnited KingdomBristolPrivate--$14B-
Luz SaudePortugalLisbonPrivate-$333M$3.2B-

Hong Kong Asia Heart Centre Public Comps

Hong Kong Asia Heart Centre is still privately-owned, but its public comps include HCA Healthcare, Alcon, Fresenius, Dr. Sulaiman Al Habib, Tenet Healthcare, IHH Healthcare, Rede D'Or São Luiz, Apollo Hospitals, Encompass Health and DaVita.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
HCA Healthcare$76B$16B1.9x1.9x9.4x9.4x
Alcon$10B$2.6B3.4x3.3x13.4x12.5x
Fresenius$26B$4.2B1.6x1.6x10.1x9.4x
Dr. Sulaiman Al Habib$3.7B$927M6.4x5.9x25.2x24.7x
Tenet Healthcare$21B$4.5B1.7x1.6x8.1x7.5x
IHH Healthcare$6.3B$1.5B3.3x3.0x13.8x13.6x
Rede D'Or São Luiz$11B$1.3B1.7x1.6x14.3x8.4x
Apollo Hospitals$2.6B$398M5.3x4.9x34.9x32.1x

This data is available for Pro users. Sign up to see all Hong Kong Asia Heart Centre competitors and their valuation data.

Start Free Trial

Common questions about Hong Kong Asia Heart Centre

When was Hong Kong Asia Heart Centre founded?Hong Kong Asia Heart Centre was founded in 1999.
Where is Hong Kong Asia Heart Centre headquartered?Hong Kong Asia Heart Centre is headquartered in Hong Kong, Hong Kong.
Is Hong Kong Asia Heart Centre publicly listed?No, Hong Kong Asia Heart Centre is a private, VC-backed company.
How much funding has Hong Kong Asia Heart Centre raised?Hong Kong Asia Heart Centre has raised $550M across 2 funding rounds.
What was Hong Kong Asia Heart Centre's last funding round?Hong Kong Asia Heart Centre's last funding round was a $400M Series D in February 2022, led by Country Garden Venture Capital and Primavera Capital Group.
Who are Hong Kong Asia Heart Centre's investors?Hong Kong Asia Heart Centre's investors include General Atlantic, ICBC International, BOCOM Intl Hldgs Co, Taikang Insurance Group, Hudson Bay Capital Management, ABC International, Primavera Capital Group, Sherpa Ventures, Legend Capital and Country Garden Venture Capital.
Which companies are comparable to Hong Kong Asia Heart Centre?Companies comparable to Hong Kong Asia Heart Centre include HCA Healthcare, Alcon, Fresenius, Dr. Sulaiman Al Habib, IVC Evidensia and Luz Saude.

See companies similar to Hong Kong Asia Heart Centre

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial